The Hydration Pharmaceuticals Company Limited (ASX:HPC)

ASX:HPC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.22	1.84	4.69	10.67	1.64
Cash & Short-Term Investments	3.22	1.84	4.69	10.67	1.64
Cash Growth	74.78%	-60.75%	-56.07%	548.95%	-39.89%
Accounts Receivable	0.34	1.74	1.3	1.01	0.79
Other Receivables	0.01	0	0.01	0	0
Receivables	0.35	1.75	1.31	1.01	0.79
Inventory	1.1	2.39	3.39	1.79	1.59
Prepaid Expenses	0.33	0.71	1.01	1.83	0.42
Total Current Assets	5	6.69	10.39	15.31	4.44
Property, Plant & Equipment	-	-	-	-	0
Total Assets	5	6.69	10.39	15.31	4.45
Accounts Payable	0.28	1.06	0.45	0.57	1.18
Accrued Expenses	1.39	2	1.87	1.49	1.16
Other Current Liabilities	0.57	0.07	0.35	-	0.09
Total Current Liabilities	2.23	3.13	2.68	2.06	2.42
Long-Term Debt	-	3.89	3.71	-	-
Other Long-Term Liabilities	0.02	0.02	0.02	0.02	0.02
Total Liabilities	2.25	7.05	6.41	2.08	2.44
Common Stock	39.67	39.33	36.61	36.41	16.49
Retained Earnings	-40.41	-43.08	-34.98	-24.37	-15.42
Comprehensive Income & Other	3.48	3.39	2.34	1.19	0.92
Shareholders' Equity	2.74	-0.36	3.98	13.23	2
Total Liabilities & Equity	5	6.69	10.39	15.31	4.45
Total Debt	-	3.89	3.71	-	-
Net Cash (Debt)	3.22	-2.05	0.98	10.67	1.64
Net Cash Growth	-	-	-90.85%	548.95%	-39.85%
Net Cash Per Share	0.01	-0.01	0.01	0.14	0.03
Filing Date Shares Outstanding	304.91	265.14	163.76	161.03	56.77
Total Common Shares Outstanding	304.91	265.14	163.76	161.03	56.77
Working Capital	2.76	3.56	7.72	13.25	2.02
Book Value Per Share	0.01	-0.00	0.02	0.08	0.04
Tangible Book Value	2.74	-0.36	3.98	13.23	2
Tangible Book Value Per Share	0.01	-0.00	0.02	0.08	0.04

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.